Laboratory of Molecular Oncology, Biomedicum, Helsinki, Finland.
Int J Cancer. 2011 Aug 1;129(3):619-28. doi: 10.1002/ijc.25720. Epub 2011 Jan 18.
Most Merkel cell carcinomas (MCCs) contain Merkel cell polyomavirus (MCPyV) DNA, and the virus likely has a pivotal role in tumor pathogenesis. p53 and the KIT receptor tyrosine kinase have also been implicated in MCC pathogenesis, but little is known about their association with MCPyV infection. We identified 207 patients diagnosed with MCC in Finland in 1979-2004 and reviewed the histological diagnoses. Adequate clinical information, tumor tissue and DNA were available from 87 confirmed MCC cases. Presence of MCPyV DNA was assessed using quantitative PCR; p53, KIT, phospho-KIT, stem cell factor (SCF) and PDGFRα expression using immunohistochemistry and presence of mutations in KIT exons 9, 11, 13 and 17 and PDGFRA exons 10, 12, 14 and 18 using DNA sequencing. Most (77.0%) of the 87 tumors contained MCPyV DNA and 37 (42.5%) expressed KIT, whereas PDGFRα, p53, SCF and pKIT expression was less common (31.9, 22.8, 8.6 and 4.8%, respectively). No KIT or PFGFRA mutations were detected, but 10 (12.5%) of the 80 tumors studied harbored common PDGFRA exon 10 S478P substitution. Tumor p53 and KIT expression were associated with absence of MCPyV DNA (p = 0.01 and 0.009, respectively). Tumor p53 expression was associated with unfavorable MCC-specific survival (p = 0.021) and overall survival (p = 0.046), but tumor KIT expression only when stratified by presence of MCPyV DNA. The results suggest that p53 and KIT expression are associated with absence of MCPyV DNA in MCC, and that the molecular pathogenesis of MCC is multifactorial.
大多数 Merkel 细胞癌(MCC)含有 Merkel 细胞多瘤病毒(MCPyV)DNA,病毒可能在肿瘤发病机制中起关键作用。p53 和 KIT 受体酪氨酸激酶也与 MCC 发病机制有关,但对其与 MCPyV 感染的关联知之甚少。我们鉴定了 1979 年至 2004 年芬兰诊断的 207 例 Merkel 细胞癌患者,并回顾了组织学诊断。从 87 例确诊的 Merkel 细胞癌病例中获得了足够的临床信息、肿瘤组织和 DNA。使用定量 PCR 评估 MCPyV DNA 的存在;使用免疫组织化学评估 p53、KIT、磷酸化 KIT、干细胞因子(SCF)和 PDGFRα 的表达;使用 DNA 测序评估 KIT 外显子 9、11、13 和 17 和 PDGFRA 外显子 10、12、14 和 18 中的突变。87 例肿瘤中,大多数(77.0%)含有 MCPyV DNA,37 例(42.5%)表达 KIT,而 PDGFRα、p53、SCF 和 pKIT 表达较少见(分别为 31.9%、22.8%、8.6%和 4.8%)。未检测到 KIT 或 PDGFRA 突变,但在研究的 80 例肿瘤中,有 10 例(12.5%)含有常见的 PDGFRA 外显子 10 S478P 取代。肿瘤 p53 和 KIT 表达与缺乏 MCPyV DNA 相关(p=0.01 和 0.009)。肿瘤 p53 表达与不良的 Merkel 细胞癌特异性生存(p=0.021)和总生存(p=0.046)相关,但仅在存在 MCPyV DNA 时与肿瘤 KIT 表达相关。结果表明,MCC 中 p53 和 KIT 表达与缺乏 MCPyV DNA 相关,MCC 的分子发病机制是多因素的。